Comprehensive Diagnosis and Management of POEMS Syndrome

Polyneuropathy Organomegaly, Endocrinopathy, Monoclonal protein and Skin changes syndrome is a rare multisystem condition with a range of manifestations which are often overlooked as trivial comorbidities, until their whole triggers the possibility of the diagnosis. The diagnosis is typically delaye...

Full description

Bibliographic Details
Main Authors: Shirley D’Sa, Jahanzaib Khwaja, Stephen Keddie, Ryan YS Keh, Duncan Smyth, Ruth Ronneberger, Suraiya Dubash, Suganya Sivabalasingham, Simon Wan, Chandrashekar Hoskote, Stephanie Baldeweg, Jonathan Sive, Michael P. Lunn
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/HS9.0000000000000796
_version_ 1797227119713976320
author Shirley D’Sa
Jahanzaib Khwaja
Stephen Keddie
Ryan YS Keh
Duncan Smyth
Ruth Ronneberger
Suraiya Dubash
Suganya Sivabalasingham
Simon Wan
Chandrashekar Hoskote
Stephanie Baldeweg
Jonathan Sive
Michael P. Lunn
author_facet Shirley D’Sa
Jahanzaib Khwaja
Stephen Keddie
Ryan YS Keh
Duncan Smyth
Ruth Ronneberger
Suraiya Dubash
Suganya Sivabalasingham
Simon Wan
Chandrashekar Hoskote
Stephanie Baldeweg
Jonathan Sive
Michael P. Lunn
author_sort Shirley D’Sa
collection DOAJ
description Polyneuropathy Organomegaly, Endocrinopathy, Monoclonal protein and Skin changes syndrome is a rare multisystem condition with a range of manifestations which are often overlooked as trivial comorbidities, until their whole triggers the possibility of the diagnosis. The diagnosis is typically delayed by 12–16 months, by which time patients can be severely disabled. There are no established consensus guidelines. We provide clinicians a comprehensive blueprint for managing POEMS from diagnostic suspicion through the work-up, selection of therapy, follow-up, and treatment of relapse based on published evidence and our large single-center experience. A multidisciplinary approach is essential including expert hematologists, neurologists, histopathologists, radiologists, and neurophysiologists. The aim of treatment is to eradicate the underlying plasma cell dyscrasia, but there are limited trial data to guide treatment decisions. Supportive care considerations include management of endocrinopathy, neuropathy, thrombosis, and infection. Response assessment is centered on clinical, neuropathy, hematological, vascular endothelial growth factor, and radiological criteria. Future clinical trials are welcomed in this setting where evidence is limited.
first_indexed 2024-04-24T14:35:44Z
format Article
id doaj.art-c63d39b172f24d7ca4ffc63a0b42d3cc
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-04-24T14:35:44Z
publishDate 2022-11-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-c63d39b172f24d7ca4ffc63a0b42d3cc2024-04-03T01:04:43ZengWileyHemaSphere2572-92412022-11-01611e79610.1097/HS9.0000000000000796202211000-00012Comprehensive Diagnosis and Management of POEMS SyndromeShirley D’Sa0Jahanzaib Khwaja1Stephen Keddie2Ryan YS Keh3Duncan Smyth4Ruth Ronneberger5Suraiya Dubash6Suganya Sivabalasingham7Simon Wan8Chandrashekar Hoskote9Stephanie Baldeweg10Jonathan Sive11Michael P. Lunn121 Department of Haematology, University College London Hospital, London, United Kingdom1 Department of Haematology, University College London Hospital, London, United Kingdom2 Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom2 Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom2 Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom3 Department of Endocrinology, University College London Hospital, London, United Kingdom4 Department of Oncology, University College London Hospital, London, United Kingdom4 Department of Oncology, University College London Hospital, London, United Kingdom5 Institute of Nuclear Medicine, University College London, United Kingdom6 Neuroradiology, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, United Kingdom3 Department of Endocrinology, University College London Hospital, London, United Kingdom1 Department of Haematology, University College London Hospital, London, United Kingdom2 Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, Queen Square, London, United KingdomPolyneuropathy Organomegaly, Endocrinopathy, Monoclonal protein and Skin changes syndrome is a rare multisystem condition with a range of manifestations which are often overlooked as trivial comorbidities, until their whole triggers the possibility of the diagnosis. The diagnosis is typically delayed by 12–16 months, by which time patients can be severely disabled. There are no established consensus guidelines. We provide clinicians a comprehensive blueprint for managing POEMS from diagnostic suspicion through the work-up, selection of therapy, follow-up, and treatment of relapse based on published evidence and our large single-center experience. A multidisciplinary approach is essential including expert hematologists, neurologists, histopathologists, radiologists, and neurophysiologists. The aim of treatment is to eradicate the underlying plasma cell dyscrasia, but there are limited trial data to guide treatment decisions. Supportive care considerations include management of endocrinopathy, neuropathy, thrombosis, and infection. Response assessment is centered on clinical, neuropathy, hematological, vascular endothelial growth factor, and radiological criteria. Future clinical trials are welcomed in this setting where evidence is limited.http://journals.lww.com/10.1097/HS9.0000000000000796
spellingShingle Shirley D’Sa
Jahanzaib Khwaja
Stephen Keddie
Ryan YS Keh
Duncan Smyth
Ruth Ronneberger
Suraiya Dubash
Suganya Sivabalasingham
Simon Wan
Chandrashekar Hoskote
Stephanie Baldeweg
Jonathan Sive
Michael P. Lunn
Comprehensive Diagnosis and Management of POEMS Syndrome
HemaSphere
title Comprehensive Diagnosis and Management of POEMS Syndrome
title_full Comprehensive Diagnosis and Management of POEMS Syndrome
title_fullStr Comprehensive Diagnosis and Management of POEMS Syndrome
title_full_unstemmed Comprehensive Diagnosis and Management of POEMS Syndrome
title_short Comprehensive Diagnosis and Management of POEMS Syndrome
title_sort comprehensive diagnosis and management of poems syndrome
url http://journals.lww.com/10.1097/HS9.0000000000000796
work_keys_str_mv AT shirleydsa comprehensivediagnosisandmanagementofpoemssyndrome
AT jahanzaibkhwaja comprehensivediagnosisandmanagementofpoemssyndrome
AT stephenkeddie comprehensivediagnosisandmanagementofpoemssyndrome
AT ryanyskeh comprehensivediagnosisandmanagementofpoemssyndrome
AT duncansmyth comprehensivediagnosisandmanagementofpoemssyndrome
AT ruthronneberger comprehensivediagnosisandmanagementofpoemssyndrome
AT suraiyadubash comprehensivediagnosisandmanagementofpoemssyndrome
AT suganyasivabalasingham comprehensivediagnosisandmanagementofpoemssyndrome
AT simonwan comprehensivediagnosisandmanagementofpoemssyndrome
AT chandrashekarhoskote comprehensivediagnosisandmanagementofpoemssyndrome
AT stephaniebaldeweg comprehensivediagnosisandmanagementofpoemssyndrome
AT jonathansive comprehensivediagnosisandmanagementofpoemssyndrome
AT michaelplunn comprehensivediagnosisandmanagementofpoemssyndrome